Bimekizumab impact on patient-reported outcomes in patients with moderate to severe hidradenitis suppurativa: Pooled Week 48 results from BE HEARD I&II. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 6, p. s476, 2024. DOI: 10.25251/skin.8.supp.476. Disponível em: https://skin.dermsquared.com/skin/article/view/3078. Acesso em: 28 apr. 2025.